Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Andelyn Biosciences Chosen for FNIH AMP BGTC Gene Therapy Partnership

Thursday, February 29, 2024

Andelyn Biosciences Inc a pioneering and patientfocused cell and gene therapy Contract Development and Manufacturing Organization has been selected to manufacture adenoassociated vectors therapies in its suspension platform for several programs under...

Phase II Study: Cadonilimab Shows Promise in Cervical Cancer

Thursday, February 29, 2024

Akeso announced that the results of a phase II clinical trial for PDCTLA bispecific antibody combined with standard treatment as firstline treatment for recurrentmetastatic cervical cancer had been published in the official journal of the American As...

Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway

Thursday, February 29, 2024

Intelligent Bio Solutions Inc a medical technology company delivering intelligent rapid noninvasive testing solutions today announced its partnership with Cliantha Research a fullservice Clinical Research

Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China

Wednesday, February 28, 2024

Tonix Pharmaceuticals Holding Corp a biopharmaceutical company with marketed products and a pipeline of development candidates announced positive results from its clinical pharmacokinetic bridging study

BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)

Wednesday, February 28, 2024

BioAegis Therapeutics a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases is pleased to announce site recruitment for BTI a Phase study of recombinant

FDA Grants Fast Track Designation to 9MW2821

Wednesday, February 28, 2024

Mabwell an innovative biopharmaceutical company with entire industry chain announces that its selfdeveloped novel ADC drug targeting Nectin has been granted Fast Track Designation by the US Food and Drug Administration for the treatment of advanced r...

Healis Therapeutics' asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea

Wednesday, February 28, 2024

Healis Therapeutics a privately held biotechnology company is thrilled to share that strategic partner Chong Kun Dang Bio has released topline results from Phase III on Healis lead compound CKDBA

4th Annual Pharma GMP and Quality Management 2024

Tuesday, February 27, 2024

Following the resounding success of its rd edition Eminence Business Media proudly presents the th Annual Pharma GMP and Quality Management scheduled for April th th at Hotel Novotel Airport Road Mumbai

Pharma Quality Excellence Awards 2024

Tuesday, February 27, 2024

The Pharma Quality Excellence Awards scheduled for April th in Hotel Novotel Airport Road Mumbai is a prestigious event aimed at recognizing and celebrating the exceptional achievements of quality departments within the pharmaceutical industry Emine...

Transthera Initiates IND-enabling Studies for TT-02332, a Novel, Highly Potent and CNS-penetrating NLRP3 Inhibitor

Tuesday, February 27, 2024

TransThera a clinicalstage biopharmaceutical company dedicated to innovating differentiated drugs globally today announced the initiation of INDenabling studies for TT a potent selective and highly